Hervé Caspard

1.7k total citations
35 papers, 1.3k citations indexed

About

Hervé Caspard is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Hervé Caspard has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 6 papers in Health and 5 papers in Infectious Diseases. Recurrent topics in Hervé Caspard's work include Influenza Virus Research Studies (15 papers), Respiratory viral infections research (15 papers) and Vaccine Coverage and Hesitancy (6 papers). Hervé Caspard is often cited by papers focused on Influenza Virus Research Studies (15 papers), Respiratory viral infections research (15 papers) and Vaccine Coverage and Hesitancy (6 papers). Hervé Caspard collaborates with scholars based in United States, United Kingdom and France. Hervé Caspard's co-authors include Christopher S. Ambrose, Emmanuel Maheu, Jean‐Marie Grouin, R.-L. Dreiser, G.B. Guillou, JoAnn E. Manson, Frank B. Hu, Alan Flint, Walter C. Willett and Robert J. Glynn and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and Cancer Research.

In The Last Decade

Hervé Caspard

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hervé Caspard United States 17 409 191 174 172 154 35 1.3k
B. Zouari Tunisia 23 403 1.0× 141 0.7× 181 1.0× 250 1.5× 47 0.3× 110 1.5k
Cengiz Utaş Türkiye 22 288 0.7× 105 0.5× 74 0.4× 306 1.8× 90 0.6× 112 1.8k
L. Clark Paramore United States 17 312 0.8× 476 2.5× 54 0.3× 120 0.7× 87 0.6× 24 1.7k
Sean Robbins United States 16 428 1.0× 377 2.0× 104 0.6× 192 1.1× 193 1.3× 23 2.0k
Martijn G.H. van Oijen Netherlands 25 504 1.2× 119 0.6× 145 0.8× 493 2.9× 22 0.1× 67 1.7k
Dahlia Weitzman Israel 20 270 0.7× 185 1.0× 112 0.6× 85 0.5× 26 0.2× 37 1.2k
H. Jorge Baluarte United States 25 189 0.5× 88 0.5× 115 0.7× 347 2.0× 56 0.4× 77 1.8k
Bella Adler Israel 16 88 0.2× 111 0.6× 109 0.6× 97 0.6× 108 0.7× 39 907
Randall S. Krakauer United States 23 226 0.6× 164 0.9× 131 0.8× 113 0.7× 77 0.5× 54 1.6k
Elie Gertner United States 23 136 0.3× 381 2.0× 103 0.6× 244 1.4× 34 0.2× 64 1.4k

Countries citing papers authored by Hervé Caspard

Since Specialization
Citations

This map shows the geographic impact of Hervé Caspard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Caspard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Caspard more than expected).

Fields of papers citing papers by Hervé Caspard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Caspard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Caspard. The network helps show where Hervé Caspard may publish in the future.

Co-authorship network of co-authors of Hervé Caspard

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Caspard. A scholar is included among the top collaborators of Hervé Caspard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Caspard. Hervé Caspard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chung, Jessie R., Brendan Flannery, Christopher S. Ambrose, et al.. (2019). Live Attenuated and Inactivated Influenza Vaccine Effectiveness. PEDIATRICS. 143(2). 38 indexed citations
2.
Caspard, Hervé, Christopher S. Ambrose, Trung N. Tran, Bradley E. Chipps, & Robert S. Zeiger. (2019). Associations Between Individual Characteristics and Blood Eosinophil Counts in Adults with Asthma or COPD. The Journal of Allergy and Clinical Immunology In Practice. 8(5). 1606–1613.e1. 15 indexed citations
3.
4.
McLean, Huong Q., Hervé Caspard, Marie R. Griffin, et al.. (2017). Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014–2015 season. Vaccine. 35(20). 2685–2693. 27 indexed citations
5.
Caspard, Hervé, Raburn M. Mallory, Jing Yu, & Christopher S. Ambrose. (2017). Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015–2016: A Systematic Review and Meta-Analysis. Open Forum Infectious Diseases. 4(3). ofx111–ofx111. 56 indexed citations
6.
Baxter, Roger, Abigail Eaton, John Hansen, et al.. (2017). Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2–49years. Vaccine. 35(9). 1254–1258. 22 indexed citations
7.
8.
Caspard, Hervé, Kathleen Coelingh, Raburn M. Mallory, & Christopher S. Ambrose. (2016). Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States. Vaccine. 34(42). 5066–5072. 33 indexed citations
9.
Caspard, Hervé, Terho Heikkinen, Robert B. Belshe, & Christopher S. Ambrose. (2016). A Systematic Review of the Efficacy of Live Attenuated Influenza Vaccine Upon Revaccination of Children. Human Vaccines & Immunotherapeutics. 12(7). 0–0. 13 indexed citations
10.
Caspard, Hervé, Manjusha Gaglani, Lydia Clipper, et al.. (2015). Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2–17 years of age in 2013–2014 in the United States. Vaccine. 34(1). 77–82. 59 indexed citations
11.
Ambrose, Christopher S., et al.. (2015). Standard methods based on last menstrual period dates misclassify and overestimate US preterm births. Journal of Perinatology. 35(6). 411–414. 10 indexed citations
12.
Tran, Trung N., et al.. (2014). Distribution of blood eosinophil in COPD patients. European Respiratory Journal. 44(Suppl 58). P4765–P4765. 1 indexed citations
13.
Antonova, Evgeniya, Christopher S. Ambrose, David M. Kern, et al.. (2014). Seasonal influenza vaccination trends from 2007–2011 in privately insured children and adults in the United States. Vaccine. 32(48). 6563–6568. 7 indexed citations
14.
Ambrose, Christopher S., Xionghua Wu, Hervé Caspard, & Robert B. Belshe. (2014). Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity. Vaccine. 32(43). 5546–5548. 14 indexed citations
15.
Flint, Alan, Kathryn M. Rexrode, Frank B. Hu, et al.. (2010). Body mass index, waist circumference, and risk of coronary heart disease: A prospective study among men and women. Obesity Research & Clinical Practice. 4(3). e171–e181. 126 indexed citations
16.
Flint, Alan, Frank B. Hu, Robert J. Glynn, et al.. (2009). Excess Weight and the Risk of Incident Coronary Heart Disease Among Men and Women. Obesity. 18(2). 377–383. 92 indexed citations
17.
Rifas‐Shiman, Sheryl L., John P. Forman, Kimberly Lane, Hervé Caspard, & Matthew W. Gillman. (2008). Diabetes and lipid screening among patients in primary care: A cohort study. BMC Health Services Research. 8(1). 25–25. 22 indexed citations
18.
Caspard, Hervé, K. Arnold Chan, & Alexander M. Walker. (2005). The long-term course of low-density lipoproteincholesterol after initiation of statin treatment: Retrospective database analysis over 3 years in health maintenance organization enrollees. Clinical Therapeutics. 27(10). 1622–1628. 2 indexed citations
19.
Caspard, Hervé, K. Arnold Chan, & Alexander M. Walker. (2005). Compliance with a statin treatment in a usual-care setting:Retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia. Clinical Therapeutics. 27(10). 1639–1646. 73 indexed citations
20.
Solal-Céligny, P., Pauline Brice, Nicole Brousse, et al.. (1996). Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.. Journal of Clinical Oncology. 14(2). 514–519. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Zouari Breakdown of academic impact, for papers by Cengiz Utaş Breakdown of academic impact, for papers by L. Clark Paramore Breakdown of academic impact, for papers by Sean Robbins Breakdown of academic impact, for papers by Martijn G.H. van Oijen Breakdown of academic impact, for papers by Dahlia Weitzman Breakdown of academic impact, for papers by H. Jorge Baluarte Breakdown of academic impact, for papers by Bella Adler Breakdown of academic impact, for papers by Randall S. Krakauer Breakdown of academic impact, for papers by Elie Gertner
Rankless by CCL
2026